• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

福氏志贺菌侵袭素复合亚单位疫苗的分离与鉴定

Isolation and characterization of a Shigella flexneri invasin complex subunit vaccine.

作者信息

Turbyfill K R, Hartman A B, Oaks E V

机构信息

Department of Enteric Infections, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910-7500, USA.

出版信息

Infect Immun. 2000 Dec;68(12):6624-32. doi: 10.1128/IAI.68.12.6624-6632.2000.

DOI:10.1128/IAI.68.12.6624-6632.2000
PMID:11083774
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC97759/
Abstract

The invasiveness and virulence of Shigella spp. are largely due to the expression of plasmid-encoded virulence factors, among which are the invasion plasmid antigens (Ipa proteins). After infection, the host immune response is directed primarily against lipopolysaccharide (LPS) and the virulence proteins (IpaB, IpaC, and IpaD). Recent observations have indicated that the Ipa proteins (IpaB, IpaC, and possibly IpaD) form a multiprotein complex capable of inducing the phagocytic event which internalizes the bacterium. We have isolated a complex of invasins and LPS from water-extractable antigens of virulent shigellae by ion-exchange chromatography. Western blot analysis of the complex indicates that all of the major virulence antigens of Shigella, including IpaB, IpaC, and IpaD, and LPS are components of this macromolecular complex. Mice or guinea pigs immunized intranasally with purified invasin complex (invaplex), without any additional adjuvant, mounted a significant immunoglobulin G (IgG) and IgA antibody response against the Shigella virulence antigens and LPS. The virulence-specific response was very similar to that previously noted in primates infected with shigellae. Guinea pigs (keratoconjunctivitis model) or mice (lethal lung model) immunized intranasally on days 0, 14, and 28 and challenged 3 weeks later with virulent shigellae were protected from disease (P<0.01 for both animal models).

摘要

志贺氏菌属的侵袭性和毒力很大程度上归因于质粒编码的毒力因子的表达,其中包括侵袭质粒抗原(Ipa蛋白)。感染后,宿主免疫反应主要针对脂多糖(LPS)和毒力蛋白(IpaB、IpaC和IpaD)。最近的观察表明,Ipa蛋白(IpaB、IpaC以及可能的IpaD)形成一种多蛋白复合物,能够诱导吞噬事件,使细菌内化。我们通过离子交换色谱法从强毒性志贺氏菌的水可提取抗原中分离出了侵袭素和LPS复合物。对该复合物的蛋白质印迹分析表明,志贺氏菌的所有主要毒力抗原,包括IpaB、IpaC和IpaD以及LPS,都是这种大分子复合物的组成成分。用纯化的侵袭素复合物(invaplex)经鼻内免疫的小鼠或豚鼠,无需任何额外佐剂,就能对志贺氏菌毒力抗原和LPS产生显著的免疫球蛋白G(IgG)和IgA抗体反应。这种毒力特异性反应与先前在感染志贺氏菌的灵长类动物中观察到的反应非常相似。在第0、14和28天经鼻内免疫,3周后用强毒性志贺氏菌攻击的豚鼠(角结膜炎模型)或小鼠(致死性肺部模型)均受到疾病保护(两种动物模型的P均<0.01)。

相似文献

1
Isolation and characterization of a Shigella flexneri invasin complex subunit vaccine.福氏志贺菌侵袭素复合亚单位疫苗的分离与鉴定
Infect Immun. 2000 Dec;68(12):6624-32. doi: 10.1128/IAI.68.12.6624-6632.2000.
2
Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.福氏志贺菌2a和宋内志贺菌双价侵袭素复合物(Invaplex)疫苗的研发与评估
Vaccine. 2006 Mar 20;24(13):2290-301. doi: 10.1016/j.vaccine.2005.11.040. Epub 2005 Dec 5.
3
Assembly, Biochemical Characterization, Immunogenicity, Adjuvanticity, and Efficacy of Artificial Invaplex.人工 Invaplex 的组装、生化特性、免疫原性、佐剂活性和功效。
mSphere. 2018 Mar 28;3(2). doi: 10.1128/mSphere.00583-17. eCollection 2018 Mar-Apr.
4
Immunogenicity and efficacy of highly purified invasin complex vaccine from Shigella flexneri 2a.福氏志贺菌2a高纯度侵袭素复合疫苗的免疫原性和效力
Vaccine. 2008 Mar 4;26(10):1353-64. doi: 10.1016/j.vaccine.2007.12.040. Epub 2008 Jan 17.
5
Shigella IpaB and IpaD displayed on L. lactis bacterium-like particles induce protective immunity in adult and infant mice.在乳酸乳球菌细菌样颗粒上展示的志贺氏菌IpaB和IpaD可在成年和幼鼠中诱导保护性免疫。
Immunol Cell Biol. 2015 Aug;93(7):641-52. doi: 10.1038/icb.2015.24. Epub 2015 Mar 17.
6
Evaluation of immunogenicity and protective efficacy of orally delivered Shigella type III secretion system proteins IpaB and IpaD.口服递送志贺氏菌 III 型分泌系统蛋白 IpaB 和 IpaD 的免疫原性和保护效力评价。
Vaccine. 2013 Jun 19;31(28):2919-29. doi: 10.1016/j.vaccine.2013.04.045. Epub 2013 May 2.
7
Development and preclinical evaluation of a trivalent, formalin-inactivated Shigella whole-cell vaccine.一种三价福尔马林灭活志贺氏菌全细胞疫苗的研发及临床前评估
Clin Vaccine Immunol. 2014 Mar;21(3):366-82. doi: 10.1128/CVI.00683-13. Epub 2014 Jan 8.
8
Intradermal delivery of Shigella IpaB and IpaD type III secretion proteins: kinetics of cell recruitment and antigen uptake, mucosal and systemic immunity, and protection across serotypes.经皮递送志贺氏菌 IpaB 和 IpaD 型 III 分泌蛋白:细胞募集和抗原摄取的动力学、黏膜和全身免疫以及针对不同血清型的保护作用。
J Immunol. 2014 Feb 15;192(4):1630-40. doi: 10.4049/jimmunol.1302743. Epub 2014 Jan 22.
9
Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccine.经鼻腔接种福氏 2a 型志贺氏菌 Invaplex 50 疫苗的安全性和免疫原性。
Vaccine. 2011 Sep 16;29(40):7009-19. doi: 10.1016/j.vaccine.2011.07.033. Epub 2011 Jul 23.
10
Broadly protective Shigella vaccine based on type III secretion apparatus proteins.基于 III 型分泌装置蛋白的广谱保护志贺氏菌疫苗。
Infect Immun. 2012 Mar;80(3):1222-31. doi: 10.1128/IAI.06174-11. Epub 2011 Dec 27.

引用本文的文献

1
Development of a Shigella conjugate vaccine targeting Shigella flexneri 6 that is immunogenic and provides protection against virulent challenge.针对福氏志贺菌 6 型的志贺氏菌结合疫苗的开发,该疫苗具有免疫原性,能提供针对强毒力挑战的保护。
Vaccine. 2024 Oct 24;42(24):126263. doi: 10.1016/j.vaccine.2024.126263. Epub 2024 Aug 31.
2
Vaccines: The Continuing Unmet Challenge.疫苗:持续未被满足的挑战。
Int J Mol Sci. 2024 Apr 13;25(8):4329. doi: 10.3390/ijms25084329.
3
Bioactivity and efficacy of a hyperimmune bovine colostrum product- Travelan, against shigellosis in a non-Human primate model (Macaca mulatta).一种高免牛初乳产品-Travelan 对非人类灵长类动物模型(猕猴)中志贺氏菌病的生物活性和疗效。
PLoS One. 2023 Dec 13;18(12):e0294021. doi: 10.1371/journal.pone.0294021. eCollection 2023.
4
A broadly immunogenic polyvalent multiepitope fusion antigen protein protects against and lethal pulmonary challenges in mice.一种具有广泛免疫原性的多价多表位融合抗原蛋白可预防和中和小鼠肺部的致死性攻击。
Infect Immun. 2023 Nov 16;91(11):e0031623. doi: 10.1128/iai.00316-23. Epub 2023 Oct 5.
5
Development of Shigella conjugate vaccines targeting Shigella flexneri 2a and S. flexneri 3a using a simple platform-approach conjugation by squaric acid chemistry.利用新型平台偶联技术——丁烯二酸化学法,研制针对福氏 2a 亚型和福氏 3a 亚型志贺菌的志贺菌结合疫苗。
Vaccine. 2023 Jul 31;41(34):4967-4977. doi: 10.1016/j.vaccine.2023.06.052. Epub 2023 Jul 1.
6
Development of the 2a, 3a, 6, and artificial Invaplex (Invaplex) vaccines.2a、3a、6 型人工 Invaplex(Invaplex)疫苗的研制。
mSphere. 2023 Aug 24;8(4):e0007323. doi: 10.1128/msphere.00073-23. Epub 2023 Jun 30.
7
Characterization of Functional B-Cell Epitopes at the Amino Terminus of Invasion Plasmid Antigen B (IpaB).入侵质粒抗原 B(IpaB)氨基末端功能 B 细胞表位的特征。
Appl Environ Microbiol. 2022 Aug 9;88(15):e0038422. doi: 10.1128/aem.00384-22. Epub 2022 Jul 20.
8
From Kiyoshi Shiga to Present-Day Shigella Vaccines: A Historical Narrative Review.从志贺洁到当代志贺氏菌疫苗:历史叙事回顾
Vaccines (Basel). 2022 Apr 20;10(5):645. doi: 10.3390/vaccines10050645.
9
From Concept to Clinical Product: A Brief History of the Novel Invaplex Vaccine's Refinement and Evolution.从概念到临床产品:新型Invaplex疫苗的优化与演进简史。
Vaccines (Basel). 2022 Apr 1;10(4):548. doi: 10.3390/vaccines10040548.
10
Recent Progress in and Vaccines.[具体疾病]及疫苗的最新进展。 (你提供的原文“Recent Progress in and Vaccines.”中两个空格处信息缺失,请补充完整以便能准确翻译。)
Pathogens. 2021 Oct 20;10(11):1353. doi: 10.3390/pathogens10111353.

本文引用的文献

1
Production of IFN-gamma and IL-10 to Shigella invasins by mononuclear cells from volunteers orally inoculated with a Shiga toxin-deleted Shigella dysenteriae type 1 strain.口服接种了缺失志贺毒素的1型痢疾志贺菌菌株的志愿者的单核细胞对志贺菌侵袭素产生γ干扰素和白细胞介素-10的情况。
J Immunol. 2000 Feb 15;164(4):2221-32. doi: 10.4049/jimmunol.164.4.2221.
2
Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.志贺氏菌感染的全球负担:对疫苗开发和控制策略实施的影响。
Bull World Health Organ. 1999;77(8):651-66.
3
Preincubation of recombinant Ipa proteins of Shigella sonnei promotes entry of non-invasive Escherichia coli into HeLa cells.宋内志贺氏菌重组Ipa蛋白的预孵育促进非侵袭性大肠杆菌进入HeLa细胞。
Microb Pathog. 1999 Oct;27(4):223-30. doi: 10.1006/mpat.1999.0300.
4
Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602.用福氏志贺菌2a减毒株SC602进行志贺菌病疫苗接种。
Infect Immun. 1999 Jul;67(7):3437-43. doi: 10.1128/IAI.67.7.3437-3443.1999.
5
IpaC induces actin polymerization and filopodia formation during Shigella entry into epithelial cells.在志贺氏菌进入上皮细胞的过程中,IpaC诱导肌动蛋白聚合和丝状伪足形成。
EMBO J. 1999 Jun 15;18(12):3249-62. doi: 10.1093/emboj/18.12.3249.
6
Strategies for mucosal vaccine development.黏膜疫苗开发策略。
Am J Trop Med Hyg. 1999 Apr;60(4 Suppl):35-45. doi: 10.4269/ajtmh.1999.60.35.
7
Rupture of the intestinal epithelial barrier and mucosal invasion by Shigella flexneri.肠上皮屏障破裂与福氏志贺菌的黏膜侵袭。
Clin Infect Dis. 1999 Mar;28(3):466-75. doi: 10.1086/515150.
8
Delivery of the non-membrane-permeative antibiotic gentamicin into mammalian cells by using Shigella flexneri membrane vesicles.利用福氏志贺氏菌膜泡将非膜渗透性抗生素庆大霉素递送至哺乳动物细胞中。
Antimicrob Agents Chemother. 1998 Jun;42(6):1476-83. doi: 10.1128/AAC.42.6.1476.
9
Identification of epitope and surface-exposed domains of Shigella flexneri invasion plasmid antigen D (IpaD).福氏志贺菌侵袭质粒抗原D(IpaD)的表位及表面暴露结构域的鉴定
Infect Immun. 1998 May;66(5):1999-2006. doi: 10.1128/IAI.66.5.1999-2006.1998.
10
Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years.泰国15年间分离出的腹泻病原体的抗生素耐药性趋势。
Clin Infect Dis. 1998 Feb;26(2):341-5. doi: 10.1086/516303.